↓ Skip to main content

The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child

Overview of attention for article published in Pediatric Nephrology, February 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
10 Mendeley
Title
The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child
Published in
Pediatric Nephrology, February 2014
DOI 10.1007/s00467-014-2772-0
Pubmed ID
Authors

Julie Ostrye, Susan M. Hailpern, Jenna Jones, Brent Egan, Katherine Chessman, Ibrahim F. Shatat

Abstract

Intravenous (IV) hydralazine is frequently used for the treatment of elevated blood pressure (BP) in hospitalized children. Its safety and efficacy have not been examined.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 20%
Malaysia 1 10%
Unknown 7 70%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 2 20%
Student > Master 2 20%
Student > Postgraduate 2 20%
Student > Doctoral Student 1 10%
Librarian 1 10%
Other 2 20%
Readers by discipline Count As %
Medicine and Dentistry 4 40%
Unspecified 3 30%
Pharmacology, Toxicology and Pharmaceutical Science 2 20%
Social Sciences 1 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2019.
All research outputs
#9,950,219
of 13,004,862 outputs
Outputs from Pediatric Nephrology
#1,571
of 2,082 outputs
Outputs of similar age
#118,192
of 187,328 outputs
Outputs of similar age from Pediatric Nephrology
#8
of 21 outputs
Altmetric has tracked 13,004,862 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,082 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,328 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.